{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:02:27Z","timestamp":1785074547696,"version":"3.55.0"},"reference-count":221,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010453","name":"National Development and Reform Commission","doi-asserted-by":"publisher","award":["WKZX2023CX060002"],"award-info":[{"award-number":["WKZX2023CX060002"]}],"id":[{"id":"10.13039\/501100010453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2025AFD774"],"award-info":[{"award-number":["2025AFD774"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbcan.2026.189610","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:00:32Z","timestamp":1778601632000},"page":"189610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neoantigen-driven personalized vaccines for breast cancer: Platforms, nano-delivery systems, and combination strategies"],"prefix":"10.1016","volume":"1881","author":[{"given":"Xiangdong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihua","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189610_bb0005","first-page":"1","article-title":"Descriptive epidemiology of female breast cancer around the world: incidence, mortality, and sociodemographic risks and disparities","author":"Elhawary","year":"2025","journal-title":"Int. J. Environ. Health Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s44197-025-00376-z","article-title":"Molecular subtypes of breast cancer in Arab women: distribution and prognostic insights","volume":"15","author":"Elkum","year":"2025","journal-title":"J. Epidemiol. Glob. Health"},{"key":"10.1016\/j.bbcan.2026.189610_bb0015","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/d41586-024-00840-z","article-title":"Cancer-vaccine trials give reasons for optimism","volume":"627","author":"Drew","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189610_bb0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-024-01649-z","article-title":"Current and future immunotherapy for breast cancer","volume":"17","author":"Heater","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007336","article-title":"Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer","volume":"11","author":"Brito Baleeiro","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0030","first-page":"274","article-title":"Neoantigen cancer vaccines: a new star on the horizon","volume":"21","author":"Li","year":"2023","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bbcan.2026.189610_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189610_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10101597","article-title":"Identification of shared neoantigens in BRCA1-related breast cancer","volume":"10","author":"Ruangapirom","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.bbcan.2026.189610_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101200","article-title":"Screening and identification of HLA-A2-restricted neoepitopes for immunotherapy in endocrine therapy-resistant breast cancer","volume":"67","author":"Wang","year":"2025","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2026.189610_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12943-023-01844-5","article-title":"The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells","volume":"22","author":"Li","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0055","first-page":"555","article-title":"INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery","volume":"33","author":"Zhang","year":"2017","journal-title":"Bioinf. (Oxf.)"},{"key":"10.1016\/j.bbcan.2026.189610_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188831","article-title":"Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer","volume":"14","author":"Mistretta","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13059-023-03005-9","article-title":"Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors","volume":"24","author":"Shi","year":"2023","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0070","first-page":"1081","article-title":"The post-translational modification, SUMOylation, and cancer (review)","volume":"52","author":"Han","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0075","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ni.1660","article-title":"Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self","volume":"9","author":"Mohammed","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0080","first-page":"346","article-title":"Glycosylation in health and disease, nature reviews","volume":"15","author":"Reily","year":"2019","journal-title":"Nephrology"},{"key":"10.1016\/j.bbcan.2026.189610_bb0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s10238-025-01820-x","article-title":"Emerging CAR immunotherapies: broadening therapeutic horizons beyond cancer","volume":"25","author":"Sueangoen","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189610_bb0090","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jconrel.2024.01.065","article-title":"A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy","volume":"367","author":"Freitas","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2026.189610_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002549","article-title":"Protein citrullination as a source of cancer neoantigens","volume":"9","author":"Katayama","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0100","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5388","article-title":"Public neoantigens in breast cancer immunotherapy (review)","volume":"54","author":"Sueangoen","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189610_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13092213","article-title":"Neoantigen-driven immunotherapy in triple-negative breast cancer: emerging strategies and clinical potential","volume":"13","author":"Shatalov","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbcan.2026.189610_bb0110","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s12885-025-13992-6","article-title":"HLA class II-restricted T cell epitopes in public neoantigens of ESR1 and PIK3CA in breast cancer","volume":"25","author":"Ando","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/bioengineering12040426","article-title":"Comprehensive analysis of oncogenic somatic alterations of mismatch repair gene in breast cancer patients","volume":"12","author":"Yan","year":"2025","journal-title":"Bioengineering"},{"key":"10.1016\/j.bbcan.2026.189610_bb0120","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41587-021-00994-5","article-title":"Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing","volume":"39","author":"Xiao","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk3487","article-title":"Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition","volume":"388","author":"Ely","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189610_bb0130","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1158\/2159-8290.CD-20-1631","article-title":"Genomes for kids: the scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing","volume":"11","author":"Newman","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189610_bb0135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41592-023-01791-5","article-title":"Single-cell proteomics enabled by next-generation sequencing or mass spectrometry","volume":"20","author":"Bennett","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbcan.2026.189610_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1347542","article-title":"Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapy","volume":"15","author":"Sng","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0145","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.csbj.2024.01.023","article-title":"Enhancing mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation","volume":"23","author":"Wei","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bbcan.2026.189610_bb0150","article-title":"Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy","volume":"12","author":"Cai","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0155","article-title":"ProGeo-neo v2.0: a one-stop software for neoantigen prediction and filtering based on the proteogenomics strategy","volume":"13","author":"Liu","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.bbcan.2026.189610_bb0160","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0165","article-title":"Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189610_bb0170","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.7150\/thno.60211","article-title":"Generation of triacyl lipopeptide-modified glycoproteins by metabolic glycoengineering as the neoantigen to boost anti-tumor immune response","volume":"11","author":"Zhao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2026.189610_bb0175","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138740","article-title":"Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control","volume":"131","author":"Lhuillier","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189610_bb0180","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1039\/D5BM00914F","article-title":"Construction strategies of whole tumor cell vaccines","volume":"13","author":"Wang","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1383978","article-title":"Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application","volume":"15","author":"Zheng","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102383","article-title":"The current clinical landscape of personalized cancer vaccines","volume":"106","author":"Fritah","year":"2022","journal-title":"Cancer Treat. Rev."},{"issue":"26","key":"10.1016\/j.bbcan.2026.189610_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202502937","article-title":"Fragment autoantigens stimulated T-Cell-Immunotherapy (FAST) as a Fast autologous cancer vaccine","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0200","doi-asserted-by":"crossref","first-page":"28675","DOI":"10.1021\/acsnano.4c06215","article-title":"Mechanotransduction-piloted whole-cell vaccines for spatiotemporal modulation of postoperative antitumor immunity","volume":"18","author":"Gu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189610_bb0205","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1158\/2326-6066.CIR-14-0058","article-title":"A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer","volume":"2","author":"Chen","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0210","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design","volume":"6","author":"Purcell","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2026.189610_bb0215","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0092-8674(01)00449-4","article-title":"Dendritic cells: specialized and regulated antigen processing machines","volume":"106","author":"Mellman","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189610_bb0220","doi-asserted-by":"crossref","first-page":"9181","DOI":"10.3390\/cimb45110576","article-title":"Recruiting in vitro transcribed mRNA against cancer immunotherapy: a contemporary appraisal of the current landscape","volume":"45","author":"Miliotou","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0225","article-title":"SARS-CoV-2 epitope-specific T cells: immunity response feature, TCR repertoire characteristics and cross-reactivity","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201496","article-title":"A potent micron neoantigen tumor vaccine GP-Neoantigen induces robust antitumor activity in multiple tumor models","volume":"9","author":"Jing","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201895","article-title":"Responsive multivesicular polymeric nanovaccines that codeliver STING agonists and neoantigens for combination tumor immunotherapy","volume":"9","author":"Su","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0240","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1158\/1078-0432.CCR-19-2741","article-title":"Results of a randomized phase IIb trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to prevent recurrences in patients with high-risk HER2 low-expressing breast cancer","volume":"26","author":"Clifton","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0245","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1158\/1078-0432.CCR-22-3578","article-title":"A phase I\/II trial of HER2 vaccine-primed autologous T-cell infusions in patients with treatment refractory HER2-overexpressing breast cancer","volume":"29","author":"Disis","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104963","article-title":"Glioblastoma vaccines: past, present, and opportunities","volume":"100","author":"Xiong","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbcan.2026.189610_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801419","article-title":"Engineering immune tolerance with biomaterials","volume":"8","author":"Gammon","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bbcan.2026.189610_bb0260","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s40200-022-01002-6","article-title":"Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overview","volume":"21","author":"Hadizadeh","year":"2022","journal-title":"J. Diab. Metab. Disord."},{"key":"10.1016\/j.bbcan.2026.189610_bb0265","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008652","article-title":"Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases","volume":"12","author":"Oltmanns","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0270","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1038\/s41467-022-33834-4","article-title":"A phase I study of an adenoviral vector delivering a MUC1\/CD40-ligand fusion protein in patients with advanced adenocarcinoma","volume":"13","author":"Tan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189610_bb0275","article-title":"In situ tumor vaccine expressing anti-CD47 antibody enhances antitumor immunity","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0280","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12967-025-06126-w","article-title":"Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma","volume":"23","author":"Scalambra","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189610_bb0285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s43556-024-00241-8","article-title":"Cancer vaccines: platforms and current progress","volume":"6","author":"Lei","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.bbcan.2026.189610_bb0290","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12929-024-01102-w","article-title":"Advances in nucleic acid-based cancer vaccines","volume":"32","author":"Liao","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0295","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12929-024-01082-x","article-title":"Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens","volume":"31","author":"Chi","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0300","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216836","article-title":"Spleen-targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma","volume":"15","author":"Wu","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189610_bb0305","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10123-023-00348-y","article-title":"Staphylococcal enterotoxin B as DNA vaccine against breast cancer in a murine model","volume":"26","author":"Halabian","year":"2023","journal-title":"Int. Microbiol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0310","doi-asserted-by":"crossref","first-page":"11817","DOI":"10.1021\/acsnano.3c02985","article-title":"Engineering the intestinal lymphatic transport of Oral nanoparticles to educate macrophages for cancer combined immunotherapy","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189610_bb0315","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamaoncol.2022.5143","article-title":"Safety and outcomes of a plasmid DNA vaccine encoding the ERBB2 intracellular domain in patients with advanced-stage ERBB2-positive breast Cancer: a phase 1 nonrandomized clinical trial","volume":"9","author":"Disis","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0320","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13073-024-01388-3","article-title":"Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients","volume":"16","author":"Zhang","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.bbcan.2026.189610_bb0325","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1158\/1538-7445.AM2025-3525","article-title":"Abstract 3525: Neo20 mRNA vaccine induces neoantigen-specific T cell immunity in humanized patient-derived xenograft mouse models of triple-negative breast cancer","volume":"85","author":"Chervo","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0330","article-title":"223 a UNITE\u00ae-based self-amplifying RNA vaccine advances anti-tumor immunity in a murine triple-negative breast cancer model","volume":"12","author":"Shen","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0335","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.actbio.2025.08.005","article-title":"Macroporous hydrogel-based mRNA cancer vaccine for in situ recruitment and modulation of dendritic cells","volume":"204","author":"Zhou","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bbcan.2026.189610_bb0340","article-title":"Engineered internal architecture of core-shell lipid nanoparticles promotes efficient mRNA endosomal release","volume":"17","author":"Li","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189610_bb0345","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1158\/1078-0432.CCR-18-3102","article-title":"Vaccine-induced memory CD8(+) T cells provide clinical benefit in HER2 expressing breast cancer: a mouse to human translational study","volume":"25","author":"Crosby","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"8107","key":"10.1016\/j.bbcan.2026.189610_bb0350","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41586-025-10004-2","article-title":"Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC","volume":"651","author":"Sahin","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189610_bb0355","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41591-024-03334-7","article-title":"Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial","volume":"31","author":"Lopez","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189610_bb0360","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0365","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2012.07.012","article-title":"Increasing the efficacy of tumor cell vaccines by enhancing cross priming","volume":"325","author":"Andersen","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189610_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16193254","article-title":"Short peptides as powerful arsenal for smart fighting cancer","volume":"16","author":"Bojarska","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189610_bb0375","doi-asserted-by":"crossref","DOI":"10.4014\/jmb.2506.06021","article-title":"Refining dendritic cell-based Cancer vaccines: subset targeting, translational barriers, and emerging strategies","volume":"35","author":"Rhee","year":"2025","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.789078","article-title":"Phase I clinical trial of an autologous dendritic cell vaccine against HER2 shows safety and preliminary clinical efficacy","volume":"11","author":"Maeng","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0385","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-025-58289-1","article-title":"Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse","volume":"16","author":"Heras-Murillo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189610_bb0390","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4049\/jimmunol.2300077","article-title":"Efficacy of a dual-epitope dendritic cell vaccine as part of combined immunotherapy for HER2-expressing breast tumors","volume":"211","author":"Vincent","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0395","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41523-025-00742-x","article-title":"A pilot study incorporating HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer","volume":"11","author":"Soliman","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16244204","article-title":"Retrospective analysis of HLA class II-restricted neoantigen peptide-pulsed dendritic cell vaccine for breast cancer","volume":"16","author":"Morisaki","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189610_bb0405","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","article-title":"Probiotic neoantigen delivery vectors for precision cancer immunotherapy","volume":"635","author":"Redenti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189610_bb0410","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2019-CT007","article-title":"Abstract CT007: safety and immunogenicity of a personalized neoantigen-Listeria vaccine in cancer patients","volume":"79","author":"Hecht","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12050531","article-title":"Differential regulation of DC function, adaptive immunity, and MyD88 dependence by two squalene emulsion-based vaccine adjuvants","volume":"12","author":"Nakkala","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.bbcan.2026.189610_bb0420","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006136","article-title":"Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors","volume":"11","author":"Lemech","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123824","article-title":"Modulating the tumour microenvironment by intratumoural injection of pattern recognition receptor agonists","volume":"12","author":"Burn","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189610_bb0430","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri.2017.131","article-title":"Towards personalized, tumour-specific, therapeutic vaccines for cancer","volume":"18","author":"Hu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0435","article-title":"Lung immune challenge study protocol: controlled exposure to inhaled resiquimod (R848) to study mechanisms of inflammation","volume":"5","author":"Jha","year":"2025","journal-title":"Immunother. Adv."},{"key":"10.1016\/j.bbcan.2026.189610_bb0440","article-title":"Advances in nanotechnology-enabled adjuvants for peptide-based cancer vaccines","volume":"18","author":"Li","year":"2025","journal-title":"Nano Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0445","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.2147\/IJN.S535460","article-title":"Nanomaterials application for STING pathway-based tumor immunotherapy","volume":"20","author":"Zhao","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbcan.2026.189610_bb0450","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1021\/acsnano.3c04471","article-title":"A cancer nanovaccine for co-delivery of peptide neoantigens and optimized combinations of STING and TLR4 agonists","volume":"18","author":"Baljon","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189610_bb0455","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/art.43095","article-title":"Metabolic stress expands polyfunctional, proinflammatory Th(17) cells in patients with Psoriatic Arthritis for whom there is Interleukin-23-independent Interleukin-17 production","volume":"77","author":"Stober","year":"2025","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbcan.2026.189610_bb0460","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1158\/1078-0432.CCR-25-2763","article-title":"A phase II trial to evaluate the safety and immunogenicity of two doses of a folate receptor alpha vaccine in patients with triple-negative breast cancer","volume":"32","author":"Knutson","year":"2026","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202504705","article-title":"A novel trained immunity adjuvant derived from commensal bacteria potentiates liposome\u2013hydrogel cancer vaccine against breast tumors","volume":"15","author":"Zhou","year":"2026","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bbcan.2026.189610_bb0470","article-title":"Novel strategies for nanovaccine application in breast cancer treatment","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0475","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12951-025-03933-7","article-title":"Emerging nano-immunotherapeutic strategies achieve metastatic colorectal cancer precision therapy","volume":"24","author":"Jiang","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0480","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13046-025-03394-8","article-title":"Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy","volume":"44","author":"Imani","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0485","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s11671-024-04118-1","article-title":"Comprehensive insights into mechanism of nanotoxicity, assessment methods and regulatory challenges of nanomedicines","volume":"19","author":"Havelikar","year":"2024","journal-title":"Discover Nano"},{"key":"10.1016\/j.bbcan.2026.189610_bb0490","article-title":"Tumor-derived CDC37 inhibits antigen cross-presentation in dendritic cells and impairs anti-tumor immunity in Breast Cancer","volume":"13","author":"Wang","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061431","article-title":"Characterization of a myeloid activation signature that correlates with survival in melanoma patients","volume":"12","author":"Kremenovic","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189610_bb0500","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-026-00910-7","article-title":"Programmable local immunochemotherapy for triple-negative breast cancer via spatiotemporally controlled release of CpG oligodeoxynucleotides, gemcitabine, and paclitaxel","volume":"12","author":"Hsieh","year":"2026","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0505","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41523-025-00776-1","article-title":"Dynamic single-cell systemic immune responses in immunotherapy-treated early-stage HR+ breast cancer patients","volume":"11","author":"Sun","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0510","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1186\/s12885-021-08601-1","article-title":"Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial","volume":"21","author":"De Caluw\u00e9","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0515","first-page":"58","article-title":"Estrogen depletion and immune activation and inflammation in women with HIV","volume":"21","author":"LaMere","year":"2026","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.bbcan.2026.189610_bb0520","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1186\/bcr2826","article-title":"Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.F.huHER2(Fo5) mice","volume":"13","author":"Ladjemi","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0525","article-title":"P09.03 hyaluronic acid as a new immunologic adjuvant in cancer: design of effective preventive and therapeutic vaccination strategies for HER2\/neu-positive breast tumors","volume":"9","author":"Carpanese","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0530","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10549-024-07492-7","article-title":"The cytokine profile correlates with less tumor-infiltrating lymphocytes in luminal a breast cancer","volume":"209","author":"Ishikawa","year":"2025","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2026.189610_bb0535","first-page":"1411","article-title":"Breast cancer immunopeptidomes contain numerous shared tumor antigens","author":"Kina","year":"2022","journal-title":"BioMed Central"},{"key":"10.1016\/j.bbcan.2026.189610_bb0540","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000455820","article-title":"Biological subtypes of triple-negative breast cancer","volume":"12","author":"Hubalek","year":"2017","journal-title":"Breast Care"},{"key":"10.1016\/j.bbcan.2026.189610_bb0545","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1038\/s41467-021-26502-6","article-title":"Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes","volume":"12","author":"Lehmann","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189610_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100736","article-title":"Genomic characteristics related to histology-based immune features in breast cancer","volume":"38","author":"Cha","year":"2025","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0555","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.677036","article-title":"How does B cell antigen presentation affect memory CD4 T cell differentiation and longevity?","volume":"12","author":"Welsh","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0560","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.ai.2016.01.001","article-title":"The role of neoantigens in naturally occurring and therapeutically induced immune responses to cancer","volume":"130","author":"Ward","year":"2016","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0565","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jconrel.2024.05.020","article-title":"Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: delivery strategies and clinical trials","volume":"370","author":"Malla","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2026.189610_bb0570","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/13543784.2021.1896702","article-title":"Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy","volume":"30","author":"Supabphol","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbcan.2026.189610_bb0575","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41526-023-00294-z","article-title":"Next generation of astronauts or ESA astronaut 2.0 concept and spotlight on immunity","volume":"9","author":"Jacob","year":"2023","journal-title":"NPJ Microgravity"},{"key":"10.1016\/j.bbcan.2026.189610_bb0580","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174278","article-title":"Targeting cellular components of the tumor microenvironment in solid malignancies","volume":"14","author":"Belli","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189610_bb0585","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41541-024-00905-0","article-title":"Immune escape of avian oncogenic Marek's disease herpesvirus and antagonistic host immune responses","volume":"9","author":"Zhu","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.bbcan.2026.189610_bb0590","article-title":"Construction and validation of antibody dependent cell phagocytosis related risk model in breast cancer","volume":"15","author":"Jiang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189610_bb0595","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2024-CT215","volume":"84","author":"Tobias","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109647","article-title":"Role of chemokines, innate and adaptive immunity","volume":"73","author":"Zimmerman","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbcan.2026.189610_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084268","article-title":"Implications of SARS-CoV-2 infection in systemic juvenile idiopathic arthritis","volume":"23","author":"Ailioaie","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0610","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10544-019-0397-6","article-title":"Investigation of parameters that determine Nano-DC vaccine transport","volume":"21","author":"Zhang","year":"2019","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.bbcan.2026.189610_bb0615","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1557\/mrs.2013.310","article-title":"Materials that harness and modulate the immune system","volume":"39","author":"Lewis","year":"2014","journal-title":"MRS Bull."},{"key":"10.1016\/j.bbcan.2026.189610_bb0620","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jconrel.2019.11.023","article-title":"Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination","volume":"317","author":"Balmert","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2026.189610_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113914","article-title":"Vaccine delivery systems toward lymph nodes","volume":"179","author":"Ding","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbcan.2026.189610_bb0630","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41541-025-01201-1","article-title":"Preserved efficacy of lyophilized SARS-CoV-2 mRNA vaccine incorporating novel ionizable lipids after one year at 25\u00b0C","volume":"10","author":"Mata","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.bbcan.2026.189610_bb0635","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1039\/D5BM00284B","article-title":"An injectable oncolytic hydrogel platform for in situ dendritic cell vaccination to boost antitumor immunity","volume":"13","author":"Wang","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2020.01.007","article-title":"Shaping humoral immunity to vaccines through antigen-displaying nanoparticles","volume":"65","author":"Irvine","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0645","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1186\/s12864-025-11898-y","article-title":"Molecular mechanism of nano-vitamin A-mediated regulation of intramuscular fat deposition involving noncoding RNAs in pigs","volume":"26","author":"Li","year":"2025","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bbcan.2026.189610_bb0650","article-title":"Modification of lipid-based nanoparticles: an efficient delivery system for nucleic acid-based immunotherapy","volume":"27","author":"Zhang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbcan.2026.189610_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16050632","article-title":"Shape matters: impact of mesoporous silica nanoparticle morphology on anti-tumor efficacy","volume":"16","author":"Fang","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbcan.2026.189610_bb0660","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189610_bb0665","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/diagnostics13111851","article-title":"[18F]FES PET resolves the diagnostic dilemma of COVID-19-vaccine-associated hypermetabolic lymphadenopathy in ER-positive breast cancer","volume":"13","author":"Nogami","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.bbcan.2026.189610_bb0670","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41551-023-01083-5","article-title":"Shortwave-infrared-light-emitting probes for the in vivo tracking of cancer vaccines and the elicited immune responses","volume":"8","author":"Ren","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bbcan.2026.189610_bb0675","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1007\/s11030-024-11038-w","article-title":"In silico screening of phytochemicals against chromatin modifier, SETD7 for remodeling of the immunosuppressive tumor microenvironment in renal cancer","volume":"29","author":"Gadewal","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bbcan.2026.189610_bb0680","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s40364-024-00714-6","article-title":"Tumor microenvironment and immunotherapy for triple-negative breast cancer","volume":"12","author":"Guo","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0685","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1038\/s41467-023-42509-7","article-title":"Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189610_bb0690","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1158\/0008-5472.CAN-21-4141","article-title":"Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade","volume":"82","author":"Jenkins","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0695","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1305531","article-title":"Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors","volume":"6","author":"Pedersen","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2026.189610_bb0700","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003371","article-title":"Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer","volume":"9","author":"Zhou","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0705","doi-asserted-by":"crossref","DOI":"10.1158\/1557-3265.SABCS24-GS3-08","article-title":"Abstract GS3-08: in situ detection of individual classical MHC-I gene products in breast cancer identifies gene- and subtype-specific biased antigen presentation loss","volume":"31","author":"Gonzalez-Ericsson","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0710","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1078062","article-title":"CD4(+) Th1 to the rescue in HER-2+ breast cancer","volume":"8","author":"Lowenfeld","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2026.189610_bb0715","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16040703","article-title":"Mechanisms of resistance and therapeutic perspectives in immunotherapy for advanced head and neck cancers","volume":"16","author":"Meci","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189610_bb0720","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4172531","article-title":"Comprehensive computational analysis of Honokiol targets for cell cycle inhibition and immunotherapy in metastatic breast cancer stem cells","volume":"2022","author":"Skolastika","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.bbcan.2026.189610_bb0725","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41523-025-00796-x","article-title":"The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer","volume":"11","author":"Fenton","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0730","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1467151","article-title":"LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling","volume":"15","author":"Jiao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0735","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1186\/s12967-025-07370-w","article-title":"Recent progress in immune evasion mechanisms of triple-negative breast cancer","volume":"23","author":"Yang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189610_bb0740","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12672-022-00506-0","article-title":"Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration","volume":"13","author":"Zhang","year":"2022","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0745","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.184128","article-title":"Boosting effect of high-dose influenza vaccination on innate immunity among elderly","volume":"10","author":"Bonduelle","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2026.189610_bb0750","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s40820-024-01533-y","article-title":"Engineered Cancer Nanovaccines: a new frontier in Cancer therapy","volume":"17","author":"Wang","year":"2024","journal-title":"Nano Micro Lett."},{"key":"10.1016\/j.bbcan.2026.189610_bb0755","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.7150\/thno.128136","article-title":"Biomimetic cell membrane-coated Nanovaccines in anti-tumor immunotherapy","volume":"16","author":"Chen","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2026.189610_bb0760","article-title":"Nanoparticles-based phototherapy systems: molecular mechanisms and clinical applications","volume":"11","author":"Chauhan","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189610_bb0765","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jconrel.2024.07.024","article-title":"Two-pronged anti-cancer nanovaccines enpowered by exogenous\/endogenous tumor-associated antigens","volume":"373","author":"Yin","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2026.189610_bb0770","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202518037","article-title":"Biomimetic organic nanozyme as tumor vaccines for targeted suppression of Ammonia-induced T lymphocyte death to augment breast cancer immunotherapy","volume":"13","author":"Suo","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0775","article-title":"Cascaded microfluidic circuits for pulsatile filtration of extracellular vesicles from whole blood for early cancer diagnosis","volume":"9","author":"Li","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2026.189610_bb0780","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41388-023-02893-2","article-title":"Functional evaluation of dendritic cells and extracellular vesicles as immunotherapy for breast cancer","volume":"43","author":"Lyu","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189610_bb0785","article-title":"Extracellular vesicles in cancer immunotherapy: therapeutic, challenges and clinical progress","volume":"20","author":"Manoochehri","year":"2025","journal-title":"Asian J. Pharmaceut. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0790","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.actbio.2021.09.003","article-title":"Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis","volume":"135","author":"Hu","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bbcan.2026.189610_bb0795","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-022-01515-x","article-title":"Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer","volume":"21","author":"Huang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0800","doi-asserted-by":"crossref","DOI":"10.1002\/adma.70627","article-title":"Engineering CRISPR system-based bacterial outer membrane vesicle potentiates T cell immunity for enhanced cancer immunotherapy","volume":"37","author":"Wang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbcan.2026.189610_bb0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009304","article-title":"Extracellular vesicles secreted by Giardia duodenalis regulate host cell innate immunity via TLR2 and NLRP3 inflammasome signaling pathways","volume":"15","author":"Zhao","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbcan.2026.189610_bb0810","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202306158","article-title":"Outer membrane vesicle-based nanohybrids target tumor-associated macrophages to enhance trained immunity-related vaccine-generated antitumor activity","volume":"35","author":"Liang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbcan.2026.189610_bb0815","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41541-025-01127-8","article-title":"GMMA decorated with mucin 1 Tn\/STn mimetics elicit specific antibodies response and inhibit tumor growth","volume":"10","author":"Pesce","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.bbcan.2026.189610_bb0820","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1021\/acsnano.3c13194","article-title":"Programmed nanocloak of commensal bacteria-derived nanovesicles amplify strong immunoreactivity against tumor growth and metastatic progression","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189610_bb0825","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409590","article-title":"A biomimetic autophagosomes-based nanovaccine boosts anticancer immunity","volume":"36","author":"Qu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbcan.2026.189610_bb0830","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1039\/D0RA09653A","article-title":"Novel albumin-binding photothermal agent ICG-IBA-RGD for targeted fluorescent imaging and photothermal therapy of cancer","volume":"11","author":"Yu","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbcan.2026.189610_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122269","article-title":"Albumin pre-opsonized membrane-active iPep nanomedicine potentiates chemo to immunotherapy of cancer","volume":"301","author":"Ji","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2026.189610_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126400","article-title":"Biohybrid nanocarriers for targeted drug delivery by integrating biological interfaces with synthetic platforms for site-specific therapeutics","volume":"687","author":"Chennamsetty","year":"2026","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbcan.2026.189610_bb0845","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040869","article-title":"Characteristics of extracellular vesicles and preclinical testing considerations prior to clinical applications","volume":"10","author":"Yoo","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbcan.2026.189610_bb0850","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jconrel.2019.04.019","article-title":"MPL nano-liposomal vaccine containing P5 HER2\/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer","volume":"303","author":"Zamani","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2026.189610_bb0855","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202403663","article-title":"Dual adjuvant-loaded peptide antigen self-assembly potentiates dendritic cell-mediated tumor immunotherapy","volume":"11","author":"Kim","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0860","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26178448","article-title":"Enhancing antitumor efficacy of MUC1 mRNA nano-vaccine by CTLA-4 siRNA-mediated immune checkpoint modulation in triple negative breast cancer mice model","volume":"26","author":"Monfaredan","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114192","article-title":"Hydrodynamic focusing to synthesize lipid-based nanoparticles: computational and experimental analysis of chip design and formulation parameters","volume":"387","author":"Abdelkarim","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2026.189610_bb0870","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202505862","article-title":"CORE: cholesterol altered lipid nanoparticles for splenic expression of mRNA payloads","author":"Narasipura","year":"2026","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bbcan.2026.189610_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126281","article-title":"Recombinant ApoE3 corona plus sucrose vitrification endows mRNA-LNPs with freeze-thaw and \u221280\u00b0C stability","volume":"685","author":"Tian","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbcan.2026.189610_bb0880","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1021\/acsnano.3c13038","article-title":"Antigen-clustered nanovaccine achieves long-term tumor remission by promoting B\/CD 4 T cell crosstalk","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189610_bb0885","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400323","article-title":"Mesoporous silica nanoparticles as an ideal platform for cancer immunotherapy: recent advances and future directions","volume":"13","author":"Godakhindi","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bbcan.2026.189610_bb0890","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16244234","article-title":"Metal oxide nanoparticles as efficient nanocarriers for targeted cancer therapy: addressing chemotherapy-induced disabilities","volume":"16","author":"Yassin","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189610_bb0895","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41565-020-00781-4","article-title":"A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy","volume":"15","author":"Xu","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0900","doi-asserted-by":"crossref","first-page":"14877","DOI":"10.1021\/acsnano.3c08425","article-title":"Syringeable near-infrared light-activated in situ immunogenic hydrogel boosts the cancer-immunity cycle to enhance anticancer immunity","volume":"18","author":"Fu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189610_bb0905","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1021\/acsnano.3c08376","article-title":"Injectable Nano-in-gel vaccine for spatial and temporal control of vaccine kinetics and breast cancer postsurgical therapy","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189610_bb0910","doi-asserted-by":"crossref","DOI":"10.2340\/biid.v13.45225","article-title":"Health and environmental hazards of shape memory polymer used in orthodontic aligners - a scoping review","volume":"13","author":"Agrawal","year":"2026","journal-title":"Biomater. Investig. Dentistry"},{"key":"10.1016\/j.bbcan.2026.189610_bb0915","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41467-017-00600-w","article-title":"Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189610_bb0920","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1021\/acs.nanolett.0c01140","article-title":"Engineering polymeric prodrug nanoplatform for vaccination immunotherapy of cancer","volume":"20","author":"Zhou","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.bbcan.2026.189610_bb0925","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.7150\/thno.107200","article-title":"pH-responsive nano-vaccine combined with anti-PD-1 antibodies for enhanced immunotherapy of breast cancer","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2026.189610_bb0930","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.apsb.2024.12.017","article-title":"NIR-II-activated whole-cell vaccine with ultra-efficient semiconducting diradical oligomers for breast carcinoma growth and metastasis inhibition","volume":"15","author":"Gao","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbcan.2026.189610_bb0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123116","article-title":"Inhibition of PDT-induced PGE2 surge for enhanced photo-immunotherapy","volume":"317","author":"Liu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2026.189610_bb0940","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s10103-025-04537-1","article-title":"A comparative study of 5-aminolevulinic acid photodynamic therapy and loop electrosurgical excision procedure in the treatment of cervical high grade squamous intraepithelial lesions","volume":"40","author":"Lu","year":"2025","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101298","article-title":"Combination of CTLA-4 blockade with MUC1 mRNA nanovaccine induces enhanced anti-tumor CTL activity by modulating tumor microenvironment of triple negative breast cancer","volume":"15","author":"Lin","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0950","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymthe.2017.10.020","article-title":"Combination immunotherapy of MUC1 mRNA nano-vaccine and CTLA-4 blockade effectively inhibits growth of triple negative breast cancer","volume":"26","author":"Liu","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2026.189610_bb0955","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010272","article-title":"Thermoresistant flagellin-adjuvanted cancer vaccine combined with photothermal therapy synergizes with anti-PD-1 treatment","volume":"13","author":"Thiruppathi","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0960","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13046-022-02307-3","article-title":"Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade","volume":"41","author":"Bai","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0965","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41417-023-00587-1","article-title":"Clinical trials of self-replicating RNA-based cancer vaccines","volume":"30","author":"Morse","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbcan.2026.189610_bb0970","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41590-019-0441-y","article-title":"PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance","volume":"20","author":"Verma","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb0975","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.trecan.2016.05.002","article-title":"Radiotherapy: changing the game in immunotherapy","volume":"2","author":"Demaria","year":"2016","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb0980","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1186\/s12964-025-02527-y","article-title":"Implications of DNA damage response and immunotherapy in tumor therapy","volume":"23","author":"Li","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbcan.2026.189610_bb0985","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/j.apsb.2021.01.003","article-title":"Alterations of DNA damage response pathway: biomarker and therapeutic strategy for cancer immunotherapy","volume":"11","author":"Jiang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbcan.2026.189610_bb0990","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1158\/2326-6066.CIR-22-0318","article-title":"A novel engineered AAV-based neoantigen vaccine in combination with radiotherapy eradicates tumors","volume":"11","author":"Huang","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb0995","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41541-024-00881-5","article-title":"Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers","volume":"9","author":"Huang","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.bbcan.2026.189610_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109946","article-title":"Stereotactic ablative radiotherapy and FAPα-based cancer vaccine suppresses metastatic tumor growth in 4T1 mouse breast cancer","volume":"189","author":"Chen","year":"2023","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2026.189610_bb1005","first-page":"27","article-title":"Facts and hopes in Radioimmunotherapy for localized stages of Cancer, clinical cancer research : an official journal of the American association for","volume":"32","author":"Bosi","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb1010","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1007\/s00262-021-02919-2","article-title":"Complete rejection of large established breast cancer by local immunochemotherapy with T cell activation against neoantigens","volume":"70","author":"Gao","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2026.189610_bb1015","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/s41590-025-02289-2","article-title":"Chemotherapy-induced CA-repeat DNA fragments in breast cancer trigger antitumor immune responses","volume":"26","author":"Zhang","year":"2025","journal-title":"Nat. Immunol."},{"issue":"37","key":"10.1016\/j.bbcan.2026.189610_bb1020","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202503238","article-title":"Cryogel-based dendritic cell immunotherapy for post-surgical breast cancer treatment","volume":"12","author":"Nguyen","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb1025","first-page":"299","article-title":"A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody","volume":"21","author":"Li","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bbcan.2026.189610_bb1030","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/jamaoncol.2015.2736","article-title":"Docetaxel alone or in combination with a therapeutic cancer vaccine (PANVAC) in patients with metastatic breast cancer: a randomized clinical trial","volume":"1","author":"Heery","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbcan.2026.189610_bb1035","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41590-025-02376-4","article-title":"Targeting autocrine retinoic acid signaling by ALDH1A2 inhibition enhances antitumor dendritic cell vaccine efficacy","volume":"27","author":"Fang","year":"2026","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb1040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17193177","article-title":"Long-acting recombinant IL-7 (rhIL-7-hyFc) enhances the primary and memory neoantigen-specific immune response to breast Cancer personalized cancer vaccines","volume":"17","author":"Chen","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189610_bb1045","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adz2294","article-title":"CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunity","volume":"10","author":"Hwang","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.bbcan.2026.189610_bb1050","series-title":"Resistance Mechanisms and Prospects of Trastuzumab","volume":"14-2024","author":"Wang","year":"2024"},{"key":"10.1016\/j.bbcan.2026.189610_bb1055","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jconrel.2023.02.011","article-title":"Recent advances in respiratory immunization: a focus on COVID-19 vaccines","volume":"355","author":"He","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2026.189610_bb1060","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1158\/1078-0432.CCR-25-1478","article-title":"Timing of recurrence after neoadjuvant chemo-immunotherapy in patients with early-stage triple-negative breast cancer","volume":"31","author":"Licata","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb1065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13058-024-01834-5","article-title":"Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the breast cancer etiology in minorities study","volume":"26","author":"John","year":"2024","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb1070","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.2147\/IJN.S520329","article-title":"Nanoformulations downregulating METTL16 combined with mRNA tumor vaccines suppress triple-negative breast cancer and prevent metastasis","volume":"20","author":"Wang","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbcan.2026.189610_bb1075","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1038\/s41467-024-53914-x","article-title":"Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189610_bb1080","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70403","article-title":"Decoding MHC loss: molecular mechanisms and implications for immune resistance in cancer","volume":"15","author":"Lin","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189610_bb1085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41523-025-00721-2","article-title":"Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality","volume":"11","author":"Bakker","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.bbcan.2026.189610_bb1090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1158\/2326-6066.CIR-25-0666","article-title":"Neoadjuvant endocrine treatment plus mammaglobin-a DNA vaccine induces antitumor immune responses in the primary tumor and peripheral blood of patients with breast Cancer: insights from a phase Ib clinical trial","volume":"14","author":"Mishra","year":"2026","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189610_bb1095","doi-asserted-by":"crossref","DOI":"10.1097\/PPO.0000000000000763","article-title":"Neoantigen vaccines in cancer prevention","volume":"31","author":"Martel-Martel","year":"2025","journal-title":"Cancer J."},{"key":"10.1016\/j.bbcan.2026.189610_bb1100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010287","article-title":"Preclinical and clinical observations implying combination therapy to enhance the efficacy of the Her-2\/neu B-cell peptide-based vaccine HER-Vaxx and to prevent immune evasion","volume":"25","author":"Tobias","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189610_bb1105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1158\/2159-8290.CD-22-0475","article-title":"The great immune escape: understanding the divergent immune response in breast cancer subtypes","volume":"13","author":"Onkar","year":"2023","journal-title":"Cancer Discov."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2600082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2600082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:34:27Z","timestamp":1785072867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X2600082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":221,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0304419X2600082X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189610","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoantigen-driven personalized vaccines for breast cancer: Platforms, nano-delivery systems, and combination strategies","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189610"}}